Most overlook this, but those patients were also on Methotrexate and some had autoimmune disorders. The study was a great idea, and the authors are great people. They wrote that the study unblinding will happen early next year, but I couldn't think of a worse study design for extrapolating to regular patients. Well, I could. (Monkey nurses with rabies fabricating data through sign language).
And I'm OK with this. The purpose of those doctors were to help their patients. It just so happened they thought they were onto something. Quite possible.
My list of stuff to try only has four things on it, and rituximab is at the bottom, but at least it's there. It's not exactly like trying foie gras. I would have to infuse it myself. I'm not sure you could find a physician in the US to even consider you a patient if this treatment was your long-term goal.
As for XMRV, everyone seems to know more about it than I do, but the Swedish authors do implicate viral lysis within B cells as a possible MOA.